Abstract: An object is to provide a communication device which can transmit different information for each lane in vehicle-to-roadside communications, while allowing vehicles to perform highly accurate position location.

Abstract: An object of the present invention is to find new pharmacological actions of urea compounds having structure represented by the general formula [1]. The urea compounds having the structure represented by the general formula [1] have excellent angiogenesis inhibitory actions. [wherein “A” is —(NR4)—, —(CR5R6)— or —O—, “B” is alkylene or alkenylene, R1, R2, R4, R5 and R6 are hydrogen, alkyl, alkenyl, adamantylalkyl or the like, R3 is aryl or an unsaturated heterocycle, and X is oxygen or sulfur].

Abstract: An object is to provide a communication device which can transmit different information for each lane in vehicle-to-roadside communications, while allowing vehicles to perform highly accurate position location.

Abstract: The present invention relates to Compounds represented by the formula (I) or salts thereof. In the formula (I), the ring A represents a benzene ring, a thiophene ring, or a pyridine ring; Ra represents a hydrogen atom, a halogen atom, an alkyl group, or an alkoxy group; the ring B represents a pyridine ring, a pyrimidine ring, or a quinoline ring; the ring C represents a benzene ring; a pyridine ring, a quinoline ring, or an isoquinoline ring; X and Y, the same or different, represent an oxygen atom or a sulfur atom, with the proviso that the case X is a sulfur atom and Y is an oxygen atom be excluded; R1 represents a hydrogen atom, a halogen atom, an amino group, a cycloalkylamino group, an alkylcarbonylamino group, an alkyloxycarbonylamino group, an alkylaminocarbonyl group, or a non-aromatic heterocyclic group; and R2 and R2?, the same or different, represent a hydrogen atom, a halogen atom, an alkyl group, a halogeno-alkyl group, or a halogeno-alkoxy group.

Abstract: The invention aims to provide a drug having an activity on inhibiting a decrease in pain threshold. Since a ?-opioid receptor agonist effectively inhibits the decrease in pain threshold, it is useful as an inhibitor of pain threshold decrease.

Abstract: An in-vehicle receiving apparatus to receive transmitted data from an on-road device having a reference position setting device to set a position satisfying a predetermined reception condition, as a reference position; a real receiving situation acquiring device to acquire a receiving situation of the transmitted data in a zone from the reference position set by the reference position setting device, to a predetermined position; a designed receiving situation estimating device to estimate a receiving situation of the transmitted data in a zone from a design position to the predetermined position when the predetermined reception condition is satisfied at the design position; and an error calculating device to calculate a distance error of the reference position from the design position, based on the receiving situation acquired by the real receiving situation acquiring device and the receiving situation estimated by the designed receiving situation estimating device.

Abstract: An object of the present invention is to find new pharmacological actions of urea compounds having structure represented by the general formula [1]. The urea compounds having the structure represented by the general formula [1] have excellent angiogenesis inhibitory actions. [wherein “A” is —(NR4)—, —(CR5R6)— or —O—, “B” is alkylene or alkenylene, R1, R2, R4, R5 and R6 are hydrogen, alkyl, alkenyl, adamantylalkyl or the like, R3 is aryl or an unsaturated heterocycle, and X is oxygen or sulfur.

Abstract: The invention aims to provide a drug having an activity on inhibiting a decrease in pain threshold. Since a ?-opioid receptor agonist effectively inhibits the decrease in pain threshold, it is useful as an inhibitor of pain threshold decrease.

Abstract: The present invention provides a method of treating rheumatic diseases comprising administering to a patient a pharmaceutically effective amount of a benzamide derivative or salts thereof. The benzamide derivative is a compound represented by the following general formula [1] or a salt thereof as an active ingredient. In the formula, R1, R2 and R3, the same or different, are hydrogen, halogen, hydroxyl, lower alkyl, lower alkoxy, aryl, aryl-lower alkyl, aryloxy, amino, amino-lower alkyl, lower alkylamino or carboxyl, X is aryl or a heterocycle, Y is a direct bond or lower alkylene wherein the lower alkylene can contain oxygen atom(s) in the group, and Z is a direct bond or lower alkylene.

Abstract: An object of the present invention is to find new pharmacological actions of urea compounds having structure represented by the general formula [1]. The urea compounds having the structure represented by the general formula [1] have excellent angiogenesis inhibitory actions. [wherein “A” is —(NR4)—, —(CR5R6)— or —O—, “B” is alkylene or alkenylene, R1, R2, R4, R5 and R6 are hydrogen, alkyl, alkenyl, adamantylalkyl or the like, R3 is aryl or an unsaturated heterocycle, and X is oxygen or sulfur.

Abstract: An object of the present invention is to find further new pharmacological actions of useful mercaptoacylcysteine derivatives. The present invention relates to therapeutic agents for osteoarthritis comprising compounds represented by the following general formula [I] or salts thereof as active ingredients. In the formula, “A” is lower alkylene. The lower alkylene is exemplified by straight-chain or branched alkylene having one to six carbon atoms such as methylene, ethylene, (dimethyl)methylene or (diethyl)methylene.